Genetic predisposition, receptor-level alterations, and impaired intracellular insulin signaling may precede weight gain and can be further aggravated by obesity-related inflammation and lipid overload, thereby amplifying metabolic and neurocognitive risk [17,18]. This evidence concerns the gene INS and obesity disorder.